Blog

HUB East 2024

Hub East: Promoting Collaboration for Program Success

As our most recently concluded conference, Access USA drew its curtains, we stood marveling at the culmination of an event that served as a confluence of experts from various disciplines within the life sciences domain. This monumental conference amalgamated three industry-leading events, all directed towards one significant arena – patient access. They created a comprehensive

Hub East: Promoting Collaboration for Program Success Read More »

optimizing patient services

Optimizing Patient Services in Pharma Manufacturing

In the dynamic terrain of the biopharmaceutical industry, patient services have surfaced as a pivotal differentiator for manufacturers. With an increased emphasis on patient-centric care, pharma manufacturers are rethinking ways to extend beyond mere provision of medication. Today’s patients seek holistic support; they demand comprehensive service programs that guide them through the intricate healthcare labyrinth

Optimizing Patient Services in Pharma Manufacturing Read More »

Patient data analytics

Optimizing Market Access in Cell and Gene Therapy with Data

The field of cell and gene therapy is rapidly transforming today’s treatment landscape for complicated cases like rare diseases. Simon Alfano, Alex Gorham, Alberto Loche, and Pablo Salazar report that biopharmaceutical companies are working diligently to develop new, life-saving products, with over 50 new cell and gene therapies launched in 2024, in an article on McKinsey & Company.

Optimizing Market Access in Cell and Gene Therapy with Data Read More »

Impacts of Step Therapy on Patient Access

Step Therapy and Market Access: Pharma’s Suppressed Struggle

In the intricate web of healthcare, where policy, economics, and patient care converge, rises a contentious practice known as step therapy. Often lauded by insurers for its cost-controlling prowess, step therapy sows seeds of uncertainty for many patients, forcing them to navigate a labyrinth of medications before laying claim to the treatment their doctors initially

Step Therapy and Market Access: Pharma’s Suppressed Struggle Read More »

Patient Non-Adherence in Specialty Pharma

Patient Non-Adherence in Specialty Pharmaceuticals Unveiled

The world of specialty pharmaceuticals consistently brings forth groundbreaking therapies, bringing hope to patients suffering from previously incurable conditions. However, their success heavily depends on patient adherence. An in-depth examination of patient journeys indicates a concerning fact – a sizeable number of patients, prescribed these potentially life-saving specialty drugs, discontinue their treatment plans frequently before their

Patient Non-Adherence in Specialty Pharmaceuticals Unveiled Read More »

team brainstorming

Coordination in Pharma: Key to Market Access Success

The pharmaceutical industry is shifting towards a model where collaboration among brand, marketing, and account field teams is not just a nice-to-have, but a strategic imperative. As access to markets becomes increasingly complex, companies that successfully align these internal functions stand to gain a significant competitive edge. In specialty pharma, where tailored approaches are often

Coordination in Pharma: Key to Market Access Success Read More »

Unlocking The Mystery: Patient Treatment Abandonment in Pharmaceuticals

Understanding Why Patients Abandon Prescribed Treatments

Navigating the patient treatment journey is like solving a complex puzzle for the pharmaceutical industry. At every turn, there are challenges, most notably the phenomenon of patient treatment abandonment. Imagine spending years developing a drug that could potentially save thousands of lives, only to find out that a significant portion of patients who should be

Understanding Why Patients Abandon Prescribed Treatments Read More »